Susquehanna International Group, LLP Lipocine Inc. Call Options Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 16, 2023	SELL	$0.3 - $0.58 $85,140 - $164,604	-283,800 Reduced 76.17%	88,800 $28,000
Q4 2022 Feb 14, 2023	SELL	$0.37 - $8.65 $851 - $19,895	-2,300 Reduced 0.61%	372,600 $149,000
Q3 2022 Nov 14, 2022	SELL	$0.49 - $7.65 $18,865 - $294,525	-38,500 Reduced 9.31%	374,900 $169,000
Q2 2022 Aug 15, 2022	SELL	$0.73 - $1.34 $76,066 - $139,628	-104,200 Reduced 20.13%	413,400 $331,000
Q1 2022 May 16, 2022	BUY	$0.89 - $1.85 $230,154 - $478,410	258,600 Added 99.85%	517,600 $709,000
Q4 2021 Feb 14, 2022	SELL	$0.99 - $1.2 $117,414 - $142,320	-118,600 Reduced 31.41%	259,000 $256,000
Q3 2021 Nov 15, 2021	SELL	$1.08 - $1.49 $181,548 - $250,469	-168,100 Reduced 30.8%	377,600 $412,000
Q2 2021 Aug 11, 2021	SELL	$1.17 - $1.59 $226,980 - $308,460	-194,000 Reduced 26.23%	545,700 $764,000
Q1 2021 May 17, 2021	BUY	$1.38 - $2.28 $884,993 - $1.46 Million	641,300 Added 651.73%	739,700 $1.12 Million
Q4 2020 Feb 16, 2021	SELL	$1.2 - $1.69 $376,800 - $530,660	-314,000 Reduced 76.14%	98,400 $134,000
Q3 2020 Nov 16, 2020	BUY	$1.21 - $2.23 $499,004 - $919,652	412,400 New	412,400 $581,000
Q1 2018 May 15, 2018	SELL	$1.18 - $3.46 $58,646 - $171,962	-49,700 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.36 - $4.35 $126,672 - $163,995	37,700 Added 314.17%	49,700 $171,000
Q3 2017 Nov 14, 2017	BUY	$3.67 - $4.19 $44,040 - $50,280	12,000	12,000 $48,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $431M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.